Occam Places Theo Karaletsos as VP, Data Science/ML at insitro
insitro, a Casdin/ARCH/GV investment, is a data-driven drug discovery and development company using machine learning and computation at scale to transform the way that drugs are discovered and developed for patients.
In 2022, Occam placed Theo Karaletsos, PhD as VP, Data Science/Machine Learning at insitro. Karaletsos joined insitro from Facebook, where he was a staff research scientist in the Probability Organization, working on probabilistic treatments and robustness of neural networks and probabilistic programming. Previously, he was a founding member and senior researcher at Uber AI Labs in San Francisco, where he worked on machine intelligence. In his earlier roles, Theo was a researcher at artificial intelligence startup Geometric Intelligence, which was acquired by Uber to form Uber AI Labs, and was a researcher at the Memorial Sloan Kettering Cancer Center. Theo did his Ph.D. work in machine learning and bioinformatics at the Max Planck Institute for Intelligent Systems.
Occam Global is an executive recruiting and leadership advisory firm with specialties across technological fields including Biotech, TechBio, AI-ML, Cell/Gene Therapy, Diagnostics/Genomics, Medical Devices, Research Tools, Digital Health, Alternative Energy, AgTech, EdTech, Robotics as well as adjacencies within Venture Capital and Private Equity. Occam helps build leadership teams that meet the demands of the rapidly developing, competitive, and challenging industries it serves. Occam Global recruits leading C-Suite executives and board members for the most exciting and innovative clients across the world with a specific focus on the UK, Continental Europe, the US, and Asia.